US FDA declines to approve Abeona's skin disorder treatment
22/04/2024 21:14
April 22 (Reuters) - Abeona Therapeutics ABEO.O said on Monday the U.S. health regulator had declined to approve its treatment for a rare skin blistering condition. (Reporting by Pratik Jain in Bengaluru; Editing by Sriraj Kalluvila) ((Pratik.Jain@thomsonreuters.com;))
Recent news on Abeona Therapeutics
See all newsBrief: Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Ultragenyx rises after FDA nod for rare disorder drug
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce
U.S. STOCKS ON THE MOVE-Cerebras, Madison Square Garden Sports